Gainers & Losers
Fri Apr 25 2025 10:23:26- Tata Consultancy Services share price
- ₹3,447.351.36%
- Tech Mahindra share price
- ₹1,461.501.06%
- Infosys share price
- ₹1,480.200.60%
- Ultratech Cement share price
- ₹12,219.250.46%
- Indusind Bank share price
- ₹822.250.32%
Active Stocks
Fri Apr 25 2025 10:29:25- Bharat Electronics share price
- ₹297.40-2.72%
- Tata Steel share price
- ₹138.70-1.98%
- Tata Power Co share price
- ₹387.30-2.20%
- Reliance Industries share price
- ₹1,300.05-0.12%
- Indian Oil Corp share price
- ₹134.60-2.75%
Business News/Market/Market Stats/Astrazeneca Pharma India share price/ Astrazeneca Pharma India Profit Loss Annual
Astrazeneca Pharma India Profit & Loss Annual
Trade8,740.45 -221.50 (-2.47%)Updated : 25 Apr 2025
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 1,295.53 | 1,002.97 | 805.60 | 813.56 |
| Total Revenue | 1,295.53 | 1,002.97 | 805.60 | 813.56 |
| Costof Revenue Total | 678.13 | 430.80 | 365.56 | 337.91 |
| Gross Profit | 617.40 | 572.17 | 440.04 | 475.65 |
| Selling/ General/ Admin Expenses Total | 418.96 | 397.16 | 343.64 | 326.58 |
| Depreciation/ Amortization | 14.94 | 16.26 | 16.95 | 20.13 |
| Unusual Expense( Income) | -15.19 | 40.23 | - | - |
| Other Operating Expenses Total | 12.07 | 9.89 | 10.09 | 13.06 |
| Total Operating Expense | 1,108.91 | 894.34 | 736.24 | 697.68 |
| Operating Income | 186.62 | 108.63 | 69.36 | 115.88 |
| Interest Inc( Exp) Net- Non- Op Total | 31.55 | 22.77 | 10.40 | 8.83 |
| Gain( Loss)on Saleof Assets | 0.03 | 2.49 | 2.82 | 2.17 |
| Other Net | 1.34 | 0.21 | 0.46 | 0.21 |
| Net Income Before Taxes | 219.54 | 134.10 | 83.04 | 127.09 |
| Provisionfor Income Taxes | 58.03 | 34.81 | 21.44 | 33.79 |
| Net Income After Taxes | 161.51 | 99.29 | 61.60 | 93.30 |
| Net Income Before Extra Items | 161.51 | 99.29 | 61.60 | 93.30 |
| Net Income | 161.51 | 99.29 | 61.60 | 93.30 |
| Income Availableto Com Excl Extra Ord | 161.51 | 99.29 | 61.60 | 93.30 |
| Income Availableto Com Incl Extra Ord | 161.51 | 99.29 | 61.60 | 93.30 |
| Diluted Net Income | 161.51 | 99.29 | 61.60 | 93.30 |
| Diluted Weighted Average Shares | 2.50 | 2.50 | 2.50 | 2.50 |
| Diluted EPS Excluding Extra Ord Items | 64.60 | 39.72 | 24.64 | 37.32 |
| DPS- Common Stock Primary Issue | 24.00 | 16.00 | 10.00 | 2.00 |
| Diluted Normalized EPS | 60.13 | 50.89 | 23.80 | 36.68 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| period Type | - | - | - | - |
*All figures in crores except per share values
Astrazeneca Pharma India Quick Links
Astrazeneca Pharma India Dividend Astrazeneca Pharma India Bonus Astrazeneca Pharma India News Astrazeneca Pharma India AGM Astrazeneca Pharma India Rights Astrazeneca Pharma India Splits Astrazeneca Pharma India Board Meetings Astrazeneca Pharma India Key Metrics Astrazeneca Pharma India Shareholdings Astrazeneca Pharma India Balance Sheet Astrazeneca Pharma India Cashflow Astrazeneca Pharma India Q1 Results Astrazeneca Pharma India Q2 Results Astrazeneca Pharma India Q3 Results Astrazeneca Pharma India Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,447.35+46.10(1.36%)
1,461.50+15.40(1.06%)
1,480.20+8.90(0.60%)
1,165.30-42.00 (-3.48%)
2,045.35-60.05 (-2.85%)